Medtronic (MDT) Tops Q1 EPS by 3c, Offers FY25 EPS Guidance
Medtronic (NYSE: MDT) reported Q1 EPS of $1.23, $0.03 better than the analyst estimate of $1.20. Revenue for the quarter came in at $7.9 billion versus the consensus estimate of $7.9 billion.
GUIDANCE:
Medtronic sees FY2025 EPS of $5.42-$5.50, versus the consensus of $5.44.
For earnings history and earnings-related data on Medtronic (MDT) click here.